Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

fludarabine 4aldesleukin 4Cyclophosphamide 4pembrolizumab 3fludarabine phosphate 2Taxes 2Radiotherapy 2Polymerase Chain Reaction 2Nicotine 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Counseling 2Cisplatin 2Bupropion 2Biopsy 2Adoptive Transfer 2motexafin gadolinium 1fluoromisonidazole 1entinostat 1durvalumab 1bintrafusp alfa protein, human 1Zinc Oxide 1Varenicline 1Tomography, X-Ray Computed 1Tobacco Use Cessation Devices 1Surgical Procedures, Operative 1Sucralfate 1Salts 1Rubidium-82 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × NHS-IL12 immunocytokine × Gastrointestinal × Clear all
NCT04287868 2026-04-13

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
51 enrolled 16 charts
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡